Acceleration of Fracture Healing by Overexpression of Basic Fibroblast Growth Factor in the Mesenchymal Stromal Cells. (Q46377157)

PubMed publication ID

28792122

21 December 2017

http://europepmc.org/abstract/MED/28792122

title

Acceleration of Fracture Healing by Overexpression of Basic Fibroblast Growth Factor in the Mesenchymal Stromal Cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6430058&resulttype=core&format=json

13 May 2020

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6430058&resulttype=core&format=json

13 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6430058&resulttype=core&format=json

13 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6430058&resulttype=core&format=json

13 May 2020

Hongliang Zhang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6430058&resulttype=core&format=json

13 May 2020

Yu-An E Lay

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6430058&resulttype=core&format=json

13 May 2020

Haiyan Chen

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6430058&resulttype=core&format=json

13 May 2020

Nancy E Lane

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6430058&resulttype=core&format=json

13 May 2020

publication date

9 August 2017

1 reference

PubMed publication ID

28792122

21 December 2017

http://europepmc.org/abstract/MED/28792122

published in

Stem Cells Translational Medicine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6430058&resulttype=core&format=json

13 May 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6430058&resulttype=core&format=json

13 May 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6430058&resulttype=core&format=json

13 May 2020

page(s)

1880-1893

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6430058&resulttype=core&format=json

Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International

13 May 2020

start time

7 December 2021

1 reference

April 2022 Public Data File from Crossref

copyrighted

0 references

cites work

Determinants of postsurgical discharge setting for male hip fracture patients

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Teriparatide (1-34 human PTH) regulation of osterix during fracture repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Aging periosteal progenitor cells have reduced regenerative responsiveness to bone injury and to the anabolic actions of PTH 1-34 treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

The role of recombinant PTH in human fracture healing: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Recent advances toward the clinical application of PTH (1-34) in fracture healing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Clinical and radiographic outcomes of posterolateral lumbar spine fusion in humans using recombinant human bone morphogenetic protein-2: an average five-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Clinical applications of BMP-7/OP-1 in fractures, nonunions and spinal fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Recombinant human bone morphogenetic protein-2 and pancreatic cancer: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Short-Term Application of Dexamethasone Enhances Bone Morphogenetic Protein-7-Induced Ectopic Bone Formation In Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Expression of angiogenic factors during distraction osteogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Fibroblast growth factor expression during skeletal fracture healing in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Effect of FGF-2 and melatonin on implant bone healing: a histomorphometric study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Accelerated fracture healing in transgenic mice overexpressing an anabolic isoform of fibroblast growth factor 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Both hPTH(1-34) and bFGF increase trabecular bone mass in osteopenic rats but they have different effects on trabecular bone architecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Basic fibroblast growth factor forms new trabeculae that physically connect with pre-existing trabeculae, and this new bone is maintained with an anti-resorptive agent and enhanced with an anabolic agent in an osteopenic rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Recombinant human basic fibroblast growth factor accelerates fracture healing by enhancing callus remodeling in experimental dog tibial fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Local application of recombinant human fibroblast growth factor-2 on bone repair: a dose-escalation prospective trial on patients with osteotomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Expansion of murine periosteal progenitor cells with fibroblast growth factor 2 reveals an intrinsic endochondral ossification program mediated by bone morphogenetic protein 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Nonamplified FGFR1 is a growth driver in malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Targeting angiogenesis in squamous non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Activation of the FGF2-FGFR1 autocrine pathway: a novel mechanism of acquired resistance to gefitinib in NSCLC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Basic fibroblast growth factor improves trabecular bone connectivity and bone strength in the lumbar vertebral body of osteopenic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Sequential treatment of ovariectomized mice with bFGF and risedronate restored trabecular bone microarchitecture and mineralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Mesenchymal stem cells expressing insulin-like growth factor-I (MSCIGF) promote fracture healing and restore new bone formation in Irs1 knockout mice: analyses of MSCIGF autocrine and paracrine regenerative effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Genetic modification of stem cells to enhance bone repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Nanobiomechanics of repair bone regenerated by genetically modified mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Characterization of a closed femur fracture model in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Development of a stable closed femoral fracture model in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Improved Mobilization of Exogenous Mesenchymal Stem Cells to Bone for Fracture Healing and Sex Difference.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Micro-CT analysis with multiple thresholds allows detection of bone formation and resorption during ultrasound-treated fracture healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Overexpression of secreted frizzled-related protein 1 inhibits bone formation and attenuates parathyroid hormone bone anabolic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Reversing bone loss by directing mesenchymal stem cells to bone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Inhibition of the progesterone nuclear receptor during the bone linear growth phase increases peak bone mass in female mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Osterix regulates calcification and degradation of chondrogenic matrices through matrix metalloproteinase 13 (MMP13) expression in association with transcription factor Runx2 during endochondral ossification

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Osterix marks distinct waves of primitive and definitive stromal progenitors during bone marrow development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Osterix-cre labeled progenitor cells contribute to the formation and maintenance of the bone marrow stroma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

In vivo fate mapping identifies mesenchymal progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Optimizing tamoxifen-inducible Cre/loxp system to reduce tamoxifen effect on bone turnover in long bones of young mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

The convergence of fracture repair and stem cells: interplay of genes, aging, environmental factors and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Basic fibroblast growth factor controls migration in human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

In vitro migration and proliferation ("wound healing") potential of mesenchymal stromal cells generated from human CD271(+) bone marrow mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Expression of smooth muscle actin in cells involved in distraction osteogenesis in a rat model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Osteoblast precursors, but not mature osteoblasts, move into developing and fractured bones along with invading blood vessels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Bone fracture healing: cell therapy in delayed unions and nonunions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

ATP autocrine/paracrine signaling induces calcium oscillations and NFAT activation in human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Vascular endothelial growth factor (VEGF-A) expression in human mesenchymal stem cells: autocrine and paracrine role on osteoblastic and endothelial differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Autocrine fibroblast growth factor 2-mediated interactions between human mesenchymal stem cells and the extracellular matrix under varying oxygen tension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Autocrine stimulation of osteoblast activity by Wnt5a in response to TNF-α in human mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Thrombin induces epithelial-mesenchymal transition and collagen production by retinal pigment epithelial cells via autocrine PDGF-receptor signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Mesenchymal stem cells: a friend or foe in immune-mediated diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Mesenchymal stromal cells: new directions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Effects on proliferation and differentiation of multipotent bone marrow stromal cells engineered to express growth factors for combined cell and gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Impaired angiogenesis, early callus formation, and late stage remodeling in fracture healing of osteopontin-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Angiogenesis is required for stress fracture healing in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

FGF signaling in the osteoprogenitor lineage non-autonomously regulates postnatal chondrocyte proliferation and skeletal growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

The role of bFGF on the ability of MSC to activate endogenous regenerative mechanisms in an ectopic bone formation model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Cell Injury-Induced Release of Fibroblast Growth Factor 2: Relevance to Intracerebral Mesenchymal Stromal Cell Transplantations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Fracture healing: mechanisms and interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Use of an alpha-smooth muscle actin GFP reporter to identify an osteoprogenitor population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Dual pathways to endochondral osteoblasts: a novel chondrocyte-derived osteoprogenitor cell identified in hypertrophic cartilage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Fate of growth plate hypertrophic chondrocytes: death or lineage extension?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

A subset of chondrogenic cells provides early mesenchymal progenitors in growing bones

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Acceleration of callus formation during fracture healing using basic fibroblast growth factor-kidney disease domain-collagen-binding domain fusion protein combined with allogenic demineralized bone powder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Randomized Placebo-Controlled and Controlled Non-Inferiority Phase III Trials Comparing Trafermin, a Recombinant Human Fibroblast Growth Factor 2, and Enamel Matrix Derivative in Periodontal Regeneration in Intrabony Defects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Recombinant human basic fibroblast growth factor (bFGF) stimulates periodontal regeneration in class II furcation defects created in beagle dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Periodontal regeneration by FGF-2 (bFGF) in primate models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

The proinflammatory cytokine, IL-6, and its interference with bFGF signaling and PSMA in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Fibroblast growth factor-2 and bone morphogenetic protein-2 have a synergistic stimulatory effect on bone formation in cell cultures from elderly mouse and human bone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Osteoblast-derived VEGF regulates osteoblast differentiation and bone formation during bone repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Production and action of transforming growth factor-beta in human osteoblast cultures: dependence on cell differentiation and modulation by calcitriol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Role of donor and host cells in muscle-derived stem cell-mediated bone repair: differentiation vs. paracrine effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Sex differences in muscle-derived stem cells and skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Effect of host sex and sex hormones on muscle-derived stem cell-mediated bone formation and defect healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Effects of Donor Age, Gender, and In Vitro Cellular Aging on the Phenotypic, Functional, and Molecular Characteristics of Mouse Bone Marrow-Derived Mesenchymal Stem Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Gender differences in injury induced mesenchymal stem cell apoptosis and VEGF, TNF, IL-6 expression: role of the 55 kDa TNF receptor (TNFR1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

The influence of sex on the chondrogenic potential of muscle-derived stem cells: implications for cartilage regeneration and repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Osteogenic potential of postnatal skeletal muscle-derived stem cells is influenced by donor sex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Regulation of Human Mesenchymal Stem Cell Functions by an Autocrine Loop Involving NAD+ Release and P2Y11-Mediated Signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSCTM.17-0039

Long bone fracture repair in mice harboring GFP reporters for cells within the osteoblastic lineage

21 January 2018

1 reference

12 December 2020

A comparative study of the bone-restorative efficacy of anabolic agents in aged ovariectomized rats

1 reference

12 December 2020

Chondrocyte-to-osteocyte Transformation in Grafts of Perichondrium-free Epiphyseal Cartilage

1 reference

12 December 2020

Repair of large osteochondral defects in rabbits using porous hydroxyapatite/collagen (HAp/Col) and fibroblast growth factor-2 (FGF-2)

1 reference

12 December 2020

Mesenchymal stem cell-conditioned medium facilitates angiogenesis and fracture healing in diabetic rats

1 reference

12 December 2020

Autocrine TGF-β induces epithelial to mesenchymal transition in human amniotic epithelial cells

1 reference

12 December 2020

Sequential BMP-2/BMP-7 delivery from polyester nanocapsules

1 reference

12 December 2020

Application of rhBMP-7 and platelet-rich plasma in the treatment of long bone non-unions

1 reference

12 December 2020

Spatial and temporal gene expression in chondrogenesis during fracture healing and the effects of basic fibroblast growth factor

1 reference

12 December 2020

Exogenous fibroblast growth factors-1 and -2 do not accelerate fracture healing in the rabbit

1 reference

12 December 2020

Enhancement of Experimental Fracture-Healing by Systemic Administration of Recombinant Human Parathyroid Hormone (PTH 1-34)

1 reference

12 December 2020

Randomized Teriparatide [human parathyroid hormone (PTH) 1-34] Once-Weekly Efficacy Research (TOWER) trial for examining the reduction in new vertebral fractures in subjects with primary osteoporosis and high fracture risk

1 reference

12 December 2020

Stimulation of fracture repair by recombinant human basic fibroblast growth factor in normal and streptozotocin-diabetic rats

1 reference

12 December 2020

Bone anabolic effects of basic fibroblast growth factor in ovariectomized rats

1 reference

12 December 2020

Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients

1 reference

12 December 2020

BMP-7-induced ectopic bone formation and fracture healing is impaired by systemic NSAID application in C57BL/6-mice

1 reference

12 December 2020

Repair of bone allograft fracture using bone morphogenetic protein-2

1 reference

12 December 2020

Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. A randomized, controlled trial

1 reference

12 December 2020

Effects of occlusal hypofunction and its recovery on PDL structure and expression of VEGF and bFGF in rats

1 reference

12 December 2020

Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions

1 reference

12 December 2020

Effects of a single percutaneous injection of basic fibroblast growth factor on the healing of a closed femoral shaft fracture in the rat

1 reference

12 December 2020

A local application of recombinant human fibroblast growth factor 2 for tibial shaft fractures: A randomized, placebo-controlled trial

1 reference

12 December 2020

An immunohistochemical analysis of the temporal and spatial expression of growth factors FGF 1, 2 and 18, IGF 1 and 2, and TGFbeta1 during distraction osteogenesis

1 reference

12 December 2020

Trans-differentiation of hypertrophic chondrocytes into cells capable of producing a mineralized bone matrix

1 reference

12 December 2020

Identifiers

DOI

10.1002/SCTM.17-0039

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6430058&resulttype=core&format=json

13 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6430058&resulttype=core&format=json

13 May 2020

PubMed publication ID

28792122

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6430058&resulttype=core&format=json